Sublingual Methadone for the Management of Cancer-related Breakthrough Pain in Outpatients

Summary

The purpose of this Phase II study is to determine the feasibility of the dose titration and assessment protocol in the outpatient population before conducting an appropriately powered phase III study. Thus the primary purpose of this study is to determine the proportion of patients who are successfully titrated to an optimal dose of sublingual (Under the tongue) methadone and then studied at that optimal dose with successive episodes of breakthrough pain.

Timeline

Start

2008-07

Primary completion

2008-09

Completion

2008-09

Drugs

Indications